Current role
Biotechnology · Healthcare
Chief Accounting Officer
2025-05-27–present
Raphael Deferiere, CPA
Chief Accounting Officer
Centessa Pharmaceuticals plc (CNTA)Equibles does not estimate personal net worth.
Get an email with a short summary when Centessa Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get CNTA alertsAbout Raphael Deferiere, CPA
Raphael Deferiere, CPA is recorded as Chief Accounting Officer at Centessa Pharmaceuticals plc (CNTA) since May 27, 2025. Centessa Pharmaceuticals plc reported in an 8-K filed May 29, 2025 that Raphael Deferiere, CPA was appointed Chief Accounting Officer, effective May 27, 2025. Centessa Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Centessa Pharmaceuticals plc includes Mario Alberto Accardi (CEO and Board Member), Francesco De Rubertis (Chairman), John Crowley (CFO) and 7 others.
“On May 27, 2025, Centessa Pharmaceuticals plc (the “Company”) appointed Raphael Deferiere, CPA, as the Company’s Chief Accounting Officer and designated him as the Company’s principal accounting officer, each effective as of May 27, 2025.”
Affiliation history
-
Current
2025-05-27–present
Company network
Leadership on record at Centessa Pharmaceuticals plc
- Mario Alberto Accardi CEO, Board Member
- Francesco De Rubertis Chairman
- John Crowley CFO
- Thomas Templeman CTO
- Iqbal Hussain General Counsel
- Gregory Weinhoff Chief Accounting Officer
- Gregory Weinhoff, M.D., M.B.A. Chief Accounting Officer
- Raphael Deferiere Chief Accounting Officer
- Christopher Stokes Board Member
- Kristina Mignon Wright Board Member